Penn Spinout Verismo Therapeutics Announces Submission of Investigational New Drug Application to the FDA for KIR-CAR T-cell Immunotherapy Candidate
Pending regulatory approval, Verismo plans to use the drug in patients with mesothelin-expressing ovarian cancer, mesothelioma and cholangiocarcinoma.
Penn Gene-Editing Spinout iEcure Receives Rare Pediatric Disease Designation from FDA for Lead Drug Candidate
iEcure is developing the new drug candidate, GTP-506, as a treatment for a rare genetic condition caused by a genetic defect in a liver enzyme responsible for detoxification of ammonia.
Philadelphia Innovation Hub Experiences Explosive Growth in Manufacturing, Research and Talent
Philadelphia's innovation hub has seen explosive growth over the past several years, with significant expansions in manufacturing and research space for multiple companies.
PCI Startup Vital Start Health Wins 2022 Citizens Small Business Community Champions Award for their Work in Neonatal Care
PCI startup Vital Start Health empowers clinicians and caregivers by giving them a digital platform to improve neonatal care.
PCI Startup ŌNŌCOR Reports First-In-Human Use of the ŌNŌ Retrieval System
Tumors within the heart affect thousands of patients around the world annually, but prior to the ŌNŌ system, open-heart surgery was the only way to remove them.
Funding Opportunity for Climate-Focused Faculty or Student Startups
Exelon Corporation and the non-profit Exelon Foundation are searching for promising early-stage companies to invest in for the 4th annual Climate Change Investment Initiative (2c2i).
President’s Innovation Prize Winner Lumify Care and PCI Startup Neuralert Hit Major Milestones in 2022
Lumify Care and Neuralert have grown rapidly in terms of funding and product expansion.
Penn Graduate Receives President’s Sustainability Prize for Robotics-Based System to Minimize Waste in Fishing Industry
Shinkei Systems cuts down on waste by reducing the likelihood that off-target species would be caught and killed, and streamlining the process to avoid waste.
Penn Spinout REGENXBIO Inc. Enters Commercial Phase; Focuses Gene Therapy on Common Cause of Blindness
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
Carisma Therapeutics CEO Steve Kelly Wins Entrepeneur of the Year for Greater Philadelphia Region
Kelly is the CEO of Carisma Therapeutics, a PCI startup that provides cellular immunotherapy for solid tumors.